ANAPA BIOTECH A/S: Financial statements 2012
CVR: 27585167
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
ANAPA BIOTECH A/S (CVR 27585167) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -2,644,415 and a net result of DKK -2,770,719. Equity in the 2012 report amounted to DKK 32,540,885. The solvency ratio was 88.7%.
- Revenue
- DKK 0
- Gross Profit
- DKK -2,644,415
- Profit/Loss
- DKK -2,770,719
- Equity
- DKK 32,540,885
- Total Assets
- DKK 36,706,571
Official annual report
Keep an eye on ANAPA BIOTECH A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout ANAPA BIOTECH A/S
ANAPA BIOTECH A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2004. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named QUANTIBACT A/S and LNA BACTERIAL DETECTION A/S. The management consists of Søren Morgenthaler Echwald. The board consists of Anette Kofod Echwald (chair), Caroline Marie Morgenthaler Echwald and Søren Morgenthaler Echwald. The company is owned by Apana Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 263,027 and a net result of DKK 488,982 compared with DKK 7,646,635 the year before. Equity in the 2025 report amounted to DKK 10,970,173.